Quantitative Models and Construction Methods Model Name: Index Component Adjustment Impact Model - **Model Construction Idea**: The model aims to measure the impact of index component adjustments on stock prices, considering the scale of passive products tracking the index and the average trading volume of the stocks[7][8][9]. - **Detailed Construction Process**: - The model calculates the impact of index adjustments using the following formula: $$ \mathrm{effect}_{s} = \frac{\sum_{i}^{m} wt_{in} * index_{-}scale_{i} - \sum_{i}^{n} wt_{out} * index_{-}scale_{i}}{avg_{-}amt_{s}} $$ where: - \( wt_{in} \) represents the buy weight of the stock in the index - \( wt_{out} \) represents the sell weight of the stock in the index - \( index_{-}scale_{i} \) represents the total scale of passive products tracking the index - \( avg_{-}amt_{s} \) represents the average daily trading volume of the stock over the past two weeks[7][8][9]. - **Model Evaluation**: The model effectively quantifies the potential trading impact on stocks due to index adjustments, providing valuable insights for identifying trading opportunities[7][8][9]. Model Backtesting Results - **Index Component Adjustment Impact Model**: - **Net Buy Scale**: - Shenghong Technology: 48.65 billion CNY[10] - Dongshan Precision: 47.91 billion CNY[10] - Guangqi Technology: 34.87 billion CNY[10] - **Impact Coefficient**: - Shenghong Technology: 0.57[10] - Dongshan Precision: 1.31[10] - Guangqi Technology: 3.37[10] Quantitative Factors and Construction Methods Factor Name: Impact Coefficient - **Factor Construction Idea**: The impact coefficient measures the potential impact on a stock's price due to changes in its index weight, considering the net adjustment scale and the stock's average trading volume[9][10][11]. - **Detailed Construction Process**: - The impact coefficient is calculated using the formula: $$ \text{Impact Coefficient} = \frac{\text{Net Adjustment Scale}}{\text{Average Daily Trading Volume}} $$ where: - Net Adjustment Scale is the net buy or sell scale of the stock due to index adjustments - Average Daily Trading Volume is the stock's average trading volume over the past two weeks[9][10][11]. - **Factor Evaluation**: The impact coefficient provides a clear measure of the potential price impact on stocks due to index adjustments, helping investors identify stocks that may experience significant price movements[9][10][11]. Factor Backtesting Results - **Impact Coefficient**: - **Stocks with Impact Coefficient > 2**: - Tower Group: 8.69[12] - Jiangzhong Pharmaceutical: 8.44[12] - Shanxi Drum Power: 6.99[12] - **Stocks with Impact Coefficient < -2**: - Deep Expressway: -15.65[14] - Wanhe Electric: -13.30[14] - Tianyoude Wine: -10.52[14]

证券研究报告 | 2025年11月30日 风险提示：海外市场动荡，全球不确定性上升。 超长债周报 TL 放量大跌 核心观点 固定收益周报 超长债复盘：上周 A 股连续反弹，万科展期一度拖累债市情绪，周五传 六大行停售五年期大额存单，并调降三年期存款产品利率，国内降息预 期升温债市小幅反弹，全周来看债市先抑后扬，超长债继续下跌。成交 方面，上周超长债交投活跃度保持平稳，交投非常活跃。利差方面，上 周超长债期限利差走平，品种利差缩窄。 超长债投资展望： 30 年国债：截至 11 月 30 日，30 年国债和 10 年国债利差为 34BP，处于 历史较低水平。从国内经济数据来看，10 月经济下行压力继续增加。我 们测算的 10 月国内 GDP 同比增速约 4.2%，增速较 9 月回落 1.1%。通胀 方面，10 月 CPI 为 0.2%，PPI 为-2.1%，通缩风险依存。我们认为，当 前债市低位震荡概率更大。一方面，去年四季度以来的经济企稳，主要 来自于中央加杠杆的托底。考虑到今年四季度增发国债的概率较低，预 计四季度政府债券融资增速继续回落，四季度国内经济依然承压。另一 方面，利率绝对水平偏低，市场对利好因素有 ...

Investment Rating - The investment rating for the company is "Outperform the Market" (maintained) [2] Core Viewpoints - The company has steadily developed into a leading chain pharmacy enterprise in China over the past 20 years, with a strong market presence in Central South, East China, and South China regions, and a total of over 14,666 stores by September 2025, serving 110 million members [3][4] - The retail pharmacy industry is undergoing a transformation from scale expansion to quality competition, with a market size of 929.3 billion yuan in 2023, growing by 6.5% year-on-year, but showing signs of slowing growth [3][46] - The company has shown slight revenue growth and strong profit growth in the first three quarters of 2025, with operating income of 17.286 billion yuan (up 0.4% year-on-year) and net profit of 1.225 billion yuan (up 10.3% year-on-year) [20][21] - The company is expected to maintain growth through refined operations and the development of a new retail system, with projected revenues of 24.546 billion yuan, 27.292 billion yuan, and 30.444 billion yuan for 2025-2027, representing year-on-year growth rates of 2.0%, 11.2%, and 11.5% respectively [3][20] Summary by Sections Company Overview - The company has expanded its operational regions and has a strong financing and acquisition capability, establishing itself as a leading chain pharmacy since its founding in 2001 [5] - The company has a clear shareholding structure, with the controlling shareholder being Chairman Gao Yi, who holds 11.67% of the shares directly [8] Industry Status - The retail pharmacy market is experiencing a decline in growth rates, with the number of retail pharmacies decreasing from 706,000 in Q3 2024 to 699,000 in Q1 2025 due to industry slowdown and online competition [3][46] - The industry is expected to see increased concentration and chain rates, with larger chain enterprises likely to gain competitive advantages over smaller pharmacies [3][46] Operational Effectiveness - The company has implemented a "fleet-type" store network strategy, enhancing customer repurchase rates through a membership system and digitalization [3][29] - The company has issued convertible bonds to raise 1.797 billion yuan for projects aimed at improving operational efficiency and logistics capabilities [18] Performance Review - The company has maintained stable expense ratios, with a gross margin of 40.4% and a net margin of 7.6% in the first three quarters of 2025 [29] - The retail business remains the primary revenue source, while the franchise and distribution business has shown significant growth, with a 17.5% increase in revenue [32] Future Outlook - The company is expected to benefit from the trend of prescription drug outflow, which is anticipated to provide new growth opportunities in the retail pharmacy market [57][62] - The company is focusing on expanding its new retail system, enhancing its O2O and B2C channels, and leveraging its large member base to drive sales [93]

证券研究报告 | 2025年11月30日 美元债双周报（25 年第 47 周） 弱于大市 经济数据陆续发布，降息预期大幅抬升 新美联储主席人选或在圣诞前宣布，热门候选人主张 12 月降息。11 月 25 日，美国财政部长斯科特·贝森特表示，美国总统特朗普极有可能在今 年圣诞节前，提名美联储主席鲍威尔的继任者。鲍威尔当前任期将于 2026年 5月结束，但特朗普此前已多次公开批评其货币政策并要求辞职。 而下一届联储主席热门候选人沃勒表示，他主张在 12 月降息。他指出， 最新数据显示劳动力市场依然疲软，不过一旦明年 1 月收到大量经济数 据后，美联储大概可以采取"逐次会议"决定的方式。与此同时，旧金 山联储主席戴利也表示支持美联储在下月会议上降息，理由是她认为就 业市场突然恶化的可能性更大，且比通胀飙升更难管理。 美国 9 月 PPI 核心通胀继续放缓。11 月 25 日周二，美国劳工统计局公布 因政府停摆而延迟的的报告，数据显示显示核心通胀持续放缓。9 月 PPI 环比上涨 0.3%符合预期，主要受能源和食品价格推动；但剔除这两项的 核心 PPI 环比仅涨 0.1%，不及预期的 0.2%。同比方面，核心 PPI ...

证券研究报告 | 2025年11月29日 2025年11月30日 多因子选股周报 动量因子表现出色，四大指增组合本周均战胜基准 核心观点 金融工程周报 国信金工指数增强组合表现跟踪 因子表现监控 以沪深 300 指数为选股空间。最近一周，三个月机构覆盖、一年动量、单季 ROE 等因子表现较好，而一个月波动、三个月反转、一个月换手等因子表 现较差。 以中证 500 指数为选股空间。最近一周，一年动量、预期净利润环比、 DELTAROE 等因子表现较好，而三个月波动、一个月波动、三个月换手等 因子表现较差。 以中证 1000 指数为选股空间。最近一周，单季营收同比增速、DELTAROA、 标准化预期外收入等因子表现较好，而三个月波动、一个月波动、三个月反 转等因子表现较差。 以中证 A500 指数为选股空间。最近一周，一年动量、标准化预期外盈利、 标准化预期外收入等因子表现较好，而一个月波动、三个月波动、预期 EPTTM 等因子表现较差。 以公募重仓指数为选股空间。最近一周，一年动量、预期净利润环比、单季 超预期幅度等因子表现较好，而一个月波动、三个月波动、一个月换手等因 子表现较差。 公募基金指数增强产品表现跟 ...

证券研究报告 | 2025年11月30日 美股市场速览 弱于大市 价格快速修复，业绩预期平稳 价格走势：多数行业与全风格显著修复 本周，标普 500 涨 3.7%，纳斯达克涨 4.9%。 风格：小盘成长（罗素 2000 成长+6.3%）＞小盘价值（罗素 2000 价值+4.7%） ＞大盘成长（罗素 1000 成长+4.2%）＞大盘价值（罗素 1000 价值+3.4%）。 22 个行业上涨，1 个行业下跌，1 个基本持平。上涨的主要有：汽车与汽车 零部件（+9.3%）、媒体与娱乐（+6.5%）、半导体产品与设备（+6.2%）、 耐用消费品与服装（+4.8%）、零售业（+4.7%）；下跌的主要有：家庭与个 人用品（-0.4%）。 资金流向：多数行业带动资金显著回流 本周，标普 500 成分股估算资金流（涨跌额 x 成交量）为+214.0（亿美元， 下同），上周为-154.0，近 4 周为-133.6，近 13 周为+492.3。 22 个行业资金流入，2 个行业资金流出。资金流入的主要有：半导体产品与 设备（+46.3）、媒体与娱乐（+43.0）、汽车与汽车零部件（+33.5）、综 合金融（+17.4）、技术硬件 ...

证券研究报告 | 2025年11月30日 港股市场速览 优于大市 价格全面修复，基本面分化明显 本周，恒生指数+2.5%，恒生综指+3.8%。风格方面，小盘（恒生小型股+3.0%） ＞中盘（恒生中型股+2.6%）＞大盘（恒生大型股+2.5%）。 主要概念指数均有所上涨。上涨幅度较大的有恒生创新药（+6.1%）和恒生 汽车（+4.5%）。 国信海外选股策略均有所上涨。上涨幅度较大的是 ROE 策略进攻型（+4.8%）。 26 个行业上涨，4 个行业下跌。上涨的主要有：轻工制造（+6.7%）、国防 军工（+6.1%）、有色金属（+5.5%）、基础化工（+5.3%）、钢铁（+5.1%）； 下跌的主要有：石油石化（-1.3%）、建筑（-0.6%）、食品饮料（-0.4%）、 综合（-0.3%）。 估值水平：多数行业稳步修复 本周，恒生指数估值（动态预期 12 个月正数市盈率，后同）+1.6%至 11.8x； 恒生综指估值+1.8%至 11.7x。 主要概念指数估值均有所上升。上升幅度较大的是恒生汽车（+5.3%至 13.8x）。 国信海外选股策略估值均有所上升。上升幅度较大的是 ROE 策略全天候型 （+4.5%至 1 ...

证券研究报告 | 2025年11月29日 宏观经济周报 服务业与制造业的共赢逻辑 在探讨经济结构转型时，许多人容易陷入一个认知误区，认为服务业与制造 业是此消彼长的对立关系。然而，全球经济发展历程告诉我们，这两大产业 更像是默契的舞伴，在全球经济舞台上相互配合、彼此成就。 反过来看，服务业也为制造业提供了全方位支撑。庞大的服务业从业群体构 成了制造业产品的核心消费力量，而服务业自身的发展也产生了对制造业产 品的巨大需求——从医疗设备到教学器材，无不如此。更具深远意义的是， 服务业承担着人力资本"加油站"的关键职能。这让我们想起计划经济时期制 造企业自办学校、医院的情景，其本质就是对服务消费保障劳动力再生产的 朴素认知。在现代经济中，教育、医疗、文娱等服务通过提升劳动者的身心 健康和知识技能，直接决定着制造业核心要素的质量。一支通过优质服务获 得更好健康和更高技能的劳动力队伍，正是制造业实现创新突破的根本保 障。 当前，中国正处于经济转型升级的关键时期。我们应当充分认识到，推动制 造业高质量发展将为研发设计、数字服务等生产性服务业创造更大空间；而 促进服务业提质扩容，特别是改善教育和医疗等公共服务，又能为制造业 ...

Investment Rating - The investment rating for the company is "Outperform the Market" [6] Core Views - The company reported a 42.5% year-on-year growth in net profit attributable to shareholders for the first half of the fiscal year 2026, driven by product and store efficiency optimization, as well as an increase in gross margin [1][3] - Same-store sales continued to show double-digit growth from October 1 to November 21, indicating a sustained positive trend [1] - The company announced an interim dividend of HKD 0.55 per share, with a payout ratio of 52% [1] Summary by Sections Financial Performance - For the first half of the fiscal year 2026, the company achieved revenue of HKD 6.843 billion, a year-on-year increase of 25.6%, and a net profit of HKD 619 million, reflecting a growth of 42.5% [1] - The gross margin improved by 2 percentage points to 34.7%, reaching a historical high, benefiting from rising gold prices and an increased proportion of high-margin priced jewelry [2] - The retail business revenue grew by 12.8%, accounting for 76.8% of total revenue, while wholesale business revenue surged by 190.6%, making up 16.3% of total revenue [2] Business Segmentation - The revenue from weight-based products increased by 11%, while fixed-price products saw a growth of 67.9%, with the latter's share rising by 8.8 percentage points to 35.7%, and the proportion of priced gold is expected to reach around 25% [2] - The revenue from the mainland China market grew by 54.2%, accounting for 43.6% of total revenue, while revenue from Hong Kong, Macau, and overseas markets increased by 9.9%, making up 56.4% [2] Future Outlook - The company is expected to continue benefiting from product innovation, channel optimization, and accelerated overseas development, with projected net profits of HKD 1.501 billion, HKD 1.787 billion, and HKD 2.028 billion for fiscal years 2026, 2027, and 2028, respectively [3][4] - The price-to-earnings ratio (PE) is projected to be 9.5, 8.0, and 7.1 for the fiscal years 2026, 2027, and 2028, indicating a favorable valuation [3][4]

Investment Rating - The report maintains an "Outperform the Market" rating for the company [6]. Core Insights - The company demonstrated a significant acceleration in revenue growth in Q3, achieving a revenue of 5.797 billion, a year-on-year increase of 28.2%, surpassing previous guidance [2]. - The adjusted operating profit for Q3 was 1.022 billion, up 14.8% year-on-year, while the adjusted net profit reached 767 million, reflecting an 11.7% increase [2]. - The company expects Q4 revenue growth to be between 25% and 30%, with double-digit same-store sales growth anticipated in both China and the U.S. [2]. - The domestic business is benefiting from a large store strategy and refined operations, with same-store sales showing a positive trend [4]. - The overseas business is expanding rapidly, with a net addition of 117 stores in Q3, bringing the total overseas store count to 3,424 [2]. Financial Performance Summary - Q3 revenue for the brand was 5.222 billion, a year-on-year increase of 22.9%, with domestic revenue at 2.909 billion, up 19.3% [2]. - The company forecasts a full-year revenue growth of 25%, with adjusted operating profit expected to be between 3.65 billion and 3.85 billion [4]. - The financial projections for 2023 to 2027 indicate a steady increase in revenue and net profit, with 2023 revenue projected at 13.839 billion, growing to 28.578 billion by 2027 [5]. - The adjusted net profit for 2023 is estimated at 2.253 billion, with a projected increase to 3.257 billion by 2027 [5].